Bayer Corporation and its entities (Bayer HealthCare Pharmaceuticals, Bayer HealthCare LLC, and Bayer AG) have agreed to pay $40 million to resolve allegations of kickbacks and false claims in connection with three of its drugs: the antifibrinolytic aprotinin (Trasylol), the statin cerivastatin (Baycol), and the antibiotic moxifloxacin (Avelox), according to the US Department of Justice (DOJ).
The settlement stems from two whistleblower lawsuits filed by Laurie Simpson, a former employee of Bayer, the DOJ said in a statement.
The author and behavioural scientist, Gad Saad, has just published a book on what he calls “suicidal empathy”. He says that “a society dies when it cares more about exhibiting infinite tolerance a...